exsulin

About:

Exsulin Corporation, a therapeutic development company, develops and commercializes drugs for the treatment of type 1 and type 2 diabetes.

Website: http://exsulin.com

Description:

Exsulin Corporation, a therapeutic development company, develops and commercializes drugs for the treatment of type 1 and type 2 diabetes. Its products include Exsulin, which uses a synthetic version of naturally-occurring peptide that induces regeneration of normal functioning pancreatic islet cells. The company was incorporated in 2006 and is based in Burnsville, Minnesota.

Total Funding Amount:

$6.44M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Burnsville, Minnesota, United States

Founded Date:

2006-01-01

Founders:

Alexander Fleming, Lisa Jansa

Number of Employees:

1-10

Last Funding Date:

2012-05-30

IPO Status:

Private

Industries:

© 2025 bioDAO.ai